Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer
Part of paid clinical trials in Sarasota, Florida.
- Sponsor
- Adenocyte, LLC
- Study ID
- NCT04793633
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- LINFU™ Technique — COMBINATION_PRODUCTNon-focused ultrasound excitation of the pancreas with IV Lumason and IV secretin injected during the ultrasound procedure.
Study Details
Adenocyte has developed LINFU®, (Low Intensity Non-Focused Ultrasound excitation of the pancreas) as a method of identifying early, asymptomatic pancreatic cancer and its noninvasive precancerous lesions. The test involves ultrasound and an analysis of pancreatic juice. A neural network-based computer-assisted system may be utilized to enhance the analysis. Patients enrolled are being screened for pancreatic cancer because they have known risk factors (i.e. smoking, diabetes, chronic pancreatitis, family history of pancreatic cancer, or certain genetic syndromes).
Key Dates
- Start date
- Jan 31, 2024
- Status verified
- Mar 2024
- Primary completion
- Dec 30, 2030
- Completion
- Dec 30, 2030
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: Patients at increased risk for developing pancreatic cancerPatients being screened for pancreatic cancer because they have known risk factors (i.e. smoking, diabetes, chronic pancreatitis, family history of pancreatic cancer, or certain genetic syndromes) or have signs or symptoms of disease and are undergoing other imaging diagnostic tests to determine if they have pancreatic cancer
Primary Outcome Measure
The number of pancreatic ductal adenocarcinomas and their noninvasive precursor [ Time Frame: 5 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sarasota Memorial HealthCare System | Sarasota | Florida | 34239 | - |
Find similar trials in Sarasota, FL
By condition
By specialty
By research site
Related Studies
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Artios Pharma Ltd · Birmingham, Alabama
- Pancreatic Cancer Early Detection ConsortiumRecruiting · Arbor Research Collaborative for Health · Phoenix, Arizona
- Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · AstraZeneca · Jacksonville, Florida
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsPHASE1/PHASE2 · Recruiting · Revolution Medicines, Inc. · Duarte, California